MindWalk
MindWalk

MindWalk

Life Sciences Tools & Services
WebsiteInvestor RelationsSEC
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

$61.7M

Market Cap • 10/16/2026

1983

(43 years)

Founded

2010

(16 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

12,5

P/S

5,3

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,1

EPS

—

Market Cap

Market Cap

61,7M

EV

58,8M

EV/Revenue

5

EV/EBITDA

-5,1

EV/EBIT

-4,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-1,7%

Total Yield

-1,7%

Dividend Yield 5Y

0%

Payout

0%

Retained Earnings

-106,2M

Profitability

Gross Margin

60,8%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

32,6%

Capex/Revenue

1,2%

Capex/D&A

21%

Capex/OCF

-1,6%

SBC/OCF

—

% PPE

23,1%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-5%

CAGR Op. Income 5Y

8,5%

CAGR Net Income 5Y

8,8%

CAGR EPS 5Y

-10,8%

CAGR OCF 5Y

41,9%

Leverage

N.D./EBITDA

0,3

Debt/Equity

0%

Current Ratio

1,8

Quick Ratio

1,6

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium